Ledger.Open graph →
SEC Form D · filed December 30, 2013

AV Therapeutics, Inc

Offering
$2.5M
Sold
$660K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Banerjee K. Debabrata · New York, NYExecMorton Coleman · New York, NYExecRobert Pollock · New York, NYExecRaj K. Tiwari · New York, NYExec · DirectorJan K. Geliebter · New York, NYExecAbraham Mittelman · New York, NYExec · DirectorJudith P. Jayson · Getzville, NYExec · DirectorSteven Heinz · Dublin, IrelandExecPeter Wagner · Menlo Park, CAExecCharles Silvey · San Francisco, CAExec · DirectorJohn Walecka · Menlo Park, CAExecDuncan Morton · Ketchum, IDExecDoug Cole · Belle Fourche, SDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗